View this email online 

The Wire

Feb. 10, 2022

Reax to SEC rules; Warburg Pincus backs Pharma Intelligence; Deal of the Year deadline tomorrow

Good morning, Hubsters. MK Flynn here on the Wire.

 

Top of mind today: the SEC’s proposed rules and how they may affect the private equity industry.

 

“The Securities and Exchange Commission crossed a threshold Wednesday that could take it into new territory in its efforts to regulate private equity,” writes Chris.

Read the story for analysis and insights from sources, including Igor Rozenblit, managing partner and founder of consultancy Iron Road Partners and former co-head of the SEC's private funds unit.

 

We’d love to hear what you think of the proposed SEC rules. How will they affect your PE firm? Will the rules foster necessary transparency, or create an undue burden on PE firms, especially smaller ones? Send us your take by emailing me at mk.flynn@peimedia.com and Chris at cwitkowsky@buyoutsinsider.com.

 

And for more analysis, see Regulatory Compliance Watch’s ongoing coverage, including this story by Bill Myers. We’ll continue covering the issues and reactions throughout our publications.

 

Pharma Intelligence. One deal announced this morning that caught my eye: Warburg Pincus has acquired Pharma Intelligence, a provider of specialist intelligence, data, and software for clinical trials, drug development and regulatory compliance, from Informa.

 

Thought leaders. Looking for insights on today’s dealmaking landscape? Check out my ongoing series of Q&As with high-profile private equity professionals, including:

• Pam Hendrickson, vice-chairman of The Riverside Company

• David Grain, founder and CEO of Grain Management

• Brent Gledhill, CEO and president of William Blair

• Beatrice Mitchell, co-founder and managing director of Sperry, Mitchell & Co. 

• Robert Reifman, managing director, Lincoln International

• Randy Schwimmer, co-head of senior lending at Churchill Asset Management and founder and publisher of The Lead Left

 

40 under 40. Private Equity International is calling for nominations for its fourth annual rising stars of private equity list. PEI’s 40 under 40: Future Leaders of Private Equity will be published online and in the Future of Private Equity Special in early May. Submit your nomination by end of day Thursday February 17 here. The list will feature individuals across five categories: Investor (LP); Fundraiser; Dealmaker; Lawyer; Operator.

 

Last chance. Time is running out to send in nominations for Buyouts’ Deal of the Year Awards. We’ll pick winners in seven categories: Deal of the Year, Large-Market Deal of the Year, Middle-Market Deal of the Year, Small-Market Deal of the Year, Turnaround of the Year, International Deal of the Year, and Secondaries Deal of the Year. The deadline is tomorrow, Friday, February 11. Send in your candidates ASAP to Chris at cwitkowsky@buyoutsinsider.com. And visit here for more info about the awards.

 

That’s it for now.

Until tomorrow,

MK

 

Read the full wire commentary on PE Hub ...

Also of note (may require subscriptions)

Antin Infrastructure Partners has raised nearly €600 million for its inaugural next generation infrastructure strategy, sources told Infrastructure Investor.

 

Third-party investors buying GP stakes is a fairly new phenomenon in infrastructure, and it is picking up steam. But what does it mean for LPs and competition? (Infrastructure Investor)

 

Investment management firm Nuveen has closed its first private equity impact fund on $218 million, undershooting its initial target of $400 million. (New Private Markets)